Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of the American College of Cardiology (JACC)
Registry data shows that comorbidities not captured in traditional surgical risk scores, particularly atrial fibrillation and poor baseline functional status, significantly impact post-TAVR outcomes in low-risk patients.
Cardiology May 6th 2025
Cath Lab Digest
DETECT AS trial showed electronic notifications increased AVR rates by 11% overall and 14% in symptomatic patients, while EARLY TAVR analyses confirmed superior outcomes with timely intervention versus surveillance, with biomarkers failing to predict optimal treatment timing.
The bRIGHT study demonstrates that T-TEER using the TriClip system can lead to sustained TR reduction and quality of life improvements in a diverse, real-world population with advanced tricuspid valve disease.
Cardiology August 20th 2024
Epoch Health
The FDA has recalled Abbott’s HeartMate 3 LVAD after reports of severe complications during implantation, including blood leakage and air entry, which can lead to serious surgical risks.
Cardiology June 5th 2024
ACP Internist
A 75-year-old man with dyspnea and exertional syncope is diagnosed with aortic stenosis. After an echocardiogram, what’s next?
Cardiology November 8th 2023
MashupMD
A faulty control arm makes a new trial for tricuspid valve regurgitation intervention seem positive. But in reality, the results probably aren’t.
Cardiology March 23rd 2023